Prescribed By :General Physician, Pulmonologist, ENT Specialist, Paediatrician
Product Description
Key Benefits of Futex 125 D/S
Second-generation cover across both gram-positive and gram-negative organisms
Stable against several beta-lactamase enzymes
Available as tablets and oral suspension for different age groups
Manufactured at a WHO-GMP certified facility under GLP and ISO norms
Every batch quality tested in-house before dispatch
Indications of Futex 125 D/S
Respiratory tract infections
ENT infections and sinusitis
Urinary tract infections
Skin and soft tissue infections
Bronchitis
How Futex 125 D/S works
Cefuroxime axetil is absorbed and converted to cefuroxime, a second-generation cephalosporin. It binds penicillin-binding proteins and halts cell wall cross-linking. Its stability against several beta-lactamases gives it broader gram-negative activity than first-generation agents while retaining useful gram-positive cover.
Why ChooseFutex 125 D/S?
Manufactured at a WHO-GMP certified facility under GLP, ISO and GMP norms, with raw material from approved vendors and in-house quality testing on every batch. Offered to PCD franchise partners on district-wise monopoly rights, with pan-India supply and complete promotional support.
Frequently asked questions about Futex 125 D/S
Is monopoly available for this product?
Yes. District-wise monopoly rights are offered across India. Tell us your district and we will confirm availability.
What is the composition of Futex 125 D/S?
Cefuroxime Axetil for Oral Suspension USP 125mg each 5 ml with water.
Is this manufactured at a WHO-GMP certified facility?
Yes. Manufacturing follows GLP, WHO, ISO and GMP norms, and every batch is quality tested in-house before dispatch.
What is the minimum order quantity?
Please contact our team for the current MOQ and price structure for your territory.
Last updated on 29 August 2026
This information is for reference only and is not a substitute for advice from a qualified doctor or pharmacist. Please consult your physician before use.